Position in PMVP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,876
-$99,901 QoQ
Shares Held
40,207
-67.6% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 64 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PMVP Over Time
Shares Held
Position Value (USD)
Derivatives in PMVP
reported options exposure · as of Jun 30, 2026CallValue
$22,244
CallShares
16,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. PMVP ranks #238 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in PMVP
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,876 | 40,207 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $22,244 | 16,600 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $153,777 | 124,014 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $623,301 | 498,641 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $534,869 | 382,050 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $75,303 | 49,870 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $110,392 | 74,089 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $265,754 | 164,046 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $47,566 | 27,980 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $84,247 | 27,177 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $239,668 | 39,034 | Shares | Defined | 2023-11-15 | |
| 2023-03-31 | $1,123,082 | 235,447 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $630,923 | 72,520 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $284,731 | 23,927 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $355,893 | 24,975 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $649,584 | 31,200 | Call | Defined | 2022-05-17 | |
| 2021-06-30 | $1,434,720 | 42,000 | Call | Defined | 2021-08-16 | |
| 2020-09-30 | $1,112,889 | 31,349 | Shares | Defined | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||